IL151596A0 - Use of lactic acid bacterium for the treatment of peritonitis - Google Patents

Use of lactic acid bacterium for the treatment of peritonitis

Info

Publication number
IL151596A0
IL151596A0 IL15159601A IL15159601A IL151596A0 IL 151596 A0 IL151596 A0 IL 151596A0 IL 15159601 A IL15159601 A IL 15159601A IL 15159601 A IL15159601 A IL 15159601A IL 151596 A0 IL151596 A0 IL 151596A0
Authority
IL
Israel
Prior art keywords
peritonitis
treatment
lactic acid
acid bacterium
bacterium
Prior art date
Application number
IL15159601A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of IL151596A0 publication Critical patent/IL151596A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/151Johnsonii
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/853Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
IL15159601A 2000-03-24 2001-03-22 Use of lactic acid bacterium for the treatment of peritonitis IL151596A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00106441 2000-03-24
PCT/EP2001/003271 WO2001070246A1 (en) 2000-03-24 2001-03-22 Use of lactic acid bacterium for the treatment of peritonitis

Publications (1)

Publication Number Publication Date
IL151596A0 true IL151596A0 (en) 2003-04-10

Family

ID=8168228

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15159601A IL151596A0 (en) 2000-03-24 2001-03-22 Use of lactic acid bacterium for the treatment of peritonitis
IL151596A IL151596A (en) 2000-03-24 2002-09-04 Use of lactic acid-producing bacteria for the preparation of an edible carrier preparation for the prevention of disorders related to edema

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151596A IL151596A (en) 2000-03-24 2002-09-04 Use of lactic acid-producing bacteria for the preparation of an edible carrier preparation for the prevention of disorders related to edema

Country Status (22)

Country Link
US (2) US7217414B2 (xx)
EP (1) EP1276488B1 (xx)
JP (1) JP2003527432A (xx)
KR (1) KR20020087418A (xx)
CN (1) CN1183916C (xx)
AR (1) AR028288A1 (xx)
AT (1) ATE348626T1 (xx)
AU (1) AU783439C (xx)
BG (1) BG107096A (xx)
BR (1) BR0109496A (xx)
CA (1) CA2403491A1 (xx)
DE (1) DE60125345T2 (xx)
ES (1) ES2276793T3 (xx)
HK (1) HK1052465B (xx)
HU (1) HUP0301059A3 (xx)
IL (2) IL151596A0 (xx)
MX (1) MXPA02009342A (xx)
NO (1) NO20024488D0 (xx)
PL (1) PL358214A1 (xx)
UA (1) UA76104C2 (xx)
WO (1) WO2001070246A1 (xx)
ZA (1) ZA200208592B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100845456B1 (ko) * 2001-02-06 2008-07-10 소시에떼 데 프로듀이 네슬레 소시에떼아노님 젖산균 및 비피도균에 의한 내독소 결합
PL205155B1 (pl) * 2001-02-19 2010-03-31 Nestle Sa Jadalny suchy produkt oraz sposób jego wytwarzania
BR0307839A (pt) * 2002-02-21 2004-12-07 Nestle Sa Composição fotoprotetora para a pele que pode ser administrada por via oral
KR20040096604A (ko) * 2002-02-21 2004-11-16 소시에떼 데 프로듀이 네슬레 소시에떼아노님 피부의 광보호용 경구 투여성 조성물
RU2334404C2 (ru) * 2002-02-21 2008-09-27 Сосьете Де Продюи Нестле С.А. Композиция корма для домашних животных для защиты их кожи от действия света
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ES2561629T3 (es) 2005-09-28 2016-02-29 Nordisk Rebalance A/S Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados
DK1992351T3 (en) * 2007-05-18 2016-06-06 Nestec Sa Lactobacillus johnsonii for the prevention of post-surgical infection
DK2123168T3 (da) * 2008-05-16 2012-04-10 Nestec Sa Lactobacillus paracasei og vægtkontrol
ES2559008T3 (es) * 2009-05-11 2016-02-10 Nestec S.A. Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
GB0914878D0 (en) 2009-08-26 2009-09-30 Plant Bioscience Ltd Competetive exclusion compositions and methods
CN105816484A (zh) * 2015-01-07 2016-08-03 东宇生物科技股份有限公司 用于腹膜透析病患预防腹膜炎并减少肾功能恶化的组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
JPH04264034A (ja) 1991-02-18 1992-09-18 Snow Brand Milk Prod Co Ltd 生体内過酸化脂質抑制剤
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
EP0577904B1 (fr) 1992-07-06 1997-05-14 Societe Des Produits Nestle S.A. Bactérie lactique
JP2712000B2 (ja) 1994-12-22 1998-02-10 ニチニチ製薬株式会社 C型肝炎治療剤
SE9501719D0 (sv) 1995-05-09 1995-05-09 Probi Ab Pharmaceutical composition
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
JPH09301877A (ja) 1996-05-13 1997-11-25 Youshindou:Kk 肝炎治療・予防剤
DE69712503T2 (de) * 1996-09-06 2002-08-29 Nestle Sa Belüftetes speiseeis mit milchsäurebakterien enthaltende beschichtung
DE29724816U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
IT1289984B1 (it) 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
AU754615B2 (en) * 1997-07-05 2002-11-21 Australasian Food Group Pty Ltd Frozen dessert
RO112995B1 (ro) * 1997-08-05 1998-03-30 Rodica Teodorescu Produs medicamentos pentru terapia colonului
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof

Also Published As

Publication number Publication date
BG107096A (bg) 2003-05-30
HK1052465A1 (en) 2003-09-19
DE60125345T2 (de) 2007-09-27
AU6212701A (en) 2001-10-03
NO20024488L (no) 2002-09-19
PL358214A1 (en) 2004-08-09
EP1276488A1 (en) 2003-01-22
WO2001070246A1 (en) 2001-09-27
NO20024488D0 (no) 2002-09-19
UA76104C2 (en) 2006-07-17
HUP0301059A2 (hu) 2003-07-28
IL151596A (en) 2008-07-08
CN1183916C (zh) 2005-01-12
ES2276793T3 (es) 2007-07-01
US7678370B2 (en) 2010-03-16
CA2403491A1 (en) 2001-09-27
CN1419454A (zh) 2003-05-21
MXPA02009342A (es) 2003-09-22
US20030044397A1 (en) 2003-03-06
DE60125345D1 (de) 2007-02-01
KR20020087418A (ko) 2002-11-22
AU783439C (en) 2006-12-14
HK1052465B (zh) 2007-05-11
AU783439B2 (en) 2005-10-27
BR0109496A (pt) 2002-12-10
US7217414B2 (en) 2007-05-15
ATE348626T1 (de) 2007-01-15
ZA200208592B (en) 2004-02-10
EP1276488B1 (en) 2006-12-20
US20070172512A1 (en) 2007-07-26
JP2003527432A (ja) 2003-09-16
HUP0301059A3 (en) 2004-10-28
AR028288A1 (es) 2003-04-30

Similar Documents

Publication Publication Date Title
MX236443B (es) Combinacion de bacterias de acido lactico y su uso para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias.
ZA200202449B (en) Use of retigabin for treating neuropathic pain.
PL350768A1 (en) Lactic acid bacteria strains capable of preventing diarrhoea
AU7616001A (en) Probiotic recolonisation therapy
IL157468A0 (en) Lactic acid bacteria as agents for treating and preventing allergy
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
IL151596A0 (en) Use of lactic acid bacterium for the treatment of peritonitis
HUP0300025A3 (en) Somnogenic activity of non-pathogenic lactic acid bacteria
IL134410A0 (en) Novel lactic acid bacteria
AP2002002483A0 (en) Lactic acid bacteria for the treatment and/or prophylaxix of giardasis
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
GB0011186D0 (en) Modification of bacteria
HUP0202345A2 (en) Method of purifying water, suitable bacteria for the method and use thereof
GB9924087D0 (en) Treatment of process fluids
HUP0301029A3 (en) Lactic acid bacteria overproducing exopolysaccharides
NO20021349D0 (no) Transformerte melkesyrebakterier
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
AU2002368208A8 (en) Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax
GB0003189D0 (en) Body treatment product
AU2002214441A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain

Legal Events

Date Code Title Description
KB Patent renewed